Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Check-up after check-in: Accor bets on online medicine for hotel rebound

Published 05/15/2020, 05:06 AM
Updated 05/15/2020, 05:10 AM
© Reuters. The logos of AccorHotels group is pictured during a news conference at the Pullman Bangkok King Power hotel, in Bangkok

PARIS (Reuters) - France's Accor (PA:ACCP), which runs hotels such as Ibis and Movenpick, said on Friday it would offer its clients free access to online medical consultations run by insurer AXA (PA:AXAF) as it prepares for a recovery from the coronavirus crisis.

France's tourism sector, which accounts for almost 8% of economic output, has been hammered by the pandemic, although companies are implementing schemes to encourage people to eventually return.

Accor and Axa said in a statement that their programme would be operational from July.

"This initiative combined with our ... enhanced hygiene protocols, will be key to rediscover the love of travel," said Sebastien Bazin, Chairman and CEO of Accor.

Accor guests would get free access to the medical network and online consultations run by French insurer AXA. Eventual face-to-face consultations or medications would be charged to clients, according to the agreement.

In France 95% of hotels are still closed, although countries around the world are slowly easing draconian lockdown measures aimed at preventing the spread of the coronavirus.

The pandemic has driven a surge in the use of online medical consultations across many countries, as the virus threat led to some anxiety among patients amid worries that seeing a doctor in person could expose them to infection.

© Reuters. The logos of AccorHotels group is pictured during a news conference at the Pullman Bangkok King Power hotel, in Bangkok

France on Thursday announced measures worth 18 billion euros ($19 billion) to support the tourism industry.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.